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It is said that hindsight is always 20/20. However, a reasoned approach to practical bioethics requires an awareness of developing technologies and their potential applications to clinical practice. As a recent example, the powerful gene editing technology, CRISPR/Cas 9 has been widely used in the laboratory both to repair genetic defects and to disrupt gene expression. Other scientists remain convinced that such research on the human germline should not be allowed at present. For example, Lanphier and his colleagues, who use CRISPR to modify somatic cells, believe that using CRISPR on germ-line cells could have unpredictable, potentially harmful effects on future generations of human beings. 4 However, they cite several examples of CRISPR-based somatic cell therapies in various stages of development, including a treatment for β-thassalemia that is scheduled to begin phase I trials later this year. 5 While using genetically modified somatic cells certainly raises concerns of safety and efficacy, those concerns are limited to the individual being treated. Our current protocols for clinical trials are designed to address such questions. But the possibility of causing heritable genetic damage remains one of the major reasons that many nations, including the US, ban research that modifies the human germline.
The technical difficulties encountered by Liang and colleagues open up the floor for meaningful bioethical discussion. Now is the time to address deep issues of what it means to be human. Are concerns about modifying the human germline simply limited to safety and efficacy? If so, such concerns will likely be resolved as technology improves. And the technology is likely to improve quickly, as other scientists continue this research and perfect their protocols. Nature news writer David Cyranoski noted in his March 18 th article that several research teams are nearing publication of work similar to the study published by Liang et al. 6 However, beyond the safety concerns lie deeper questions. Certainly the ability to edit the genome brings with it all kinds of therapeutic possibilities. At the same time, there is no reason why someone could not use this technology to modify the human species, with good or evil intent. Our genetics are an integral part of what make us human. We now hold tools which would allow modification of the human genome on a much faster time frame than we have ever observed in nature. If we believe that modification of the human genome should be restricted to therapeutic uses, or even banned altogether, now is the time to frame those arguments. Now is the time for theoreticians and pragmatists to join forces, talk through the issues, and set policies. Regulations and laws need to be passed before embryonic human lives are irreversibly impacted.
How does our use of genetic technology impact us as human persons, and as a biological species? The window for discussion of these issues is closing as the technology continues to progress. It is time to speak up, or forever hold our peace.
